FDA (Tag Archives)

Subscribe to PricePlow's Newsletter and FDA Alerts

Topic Blog Posts YouTube Videos Instagram Posts
FDA

“IMO Fiber” No More! FDA DENIES Isomaltooligosaccharide Fiber Status!

January 2020 Update: After reviewing BioNeutra’s petition against this June 2018 decision, FDA has submitted their FINAL ANSWER on January 9, 2020: IMO IS NOT A FIBER.

You can skip down to the 2020 Final Answer Update at the

[…]

Continue Reading →

Posted on by in , , | 3 Comments

Supplement Manufacturer ABH Pharma INDICTED After Years of FDA Violations

ABH Pharma Update: Nutrex Research has released a statement regarding this recall. See our brand statements section at the bottom of this post to learn more.

Many consumers quickly glance at the label on a dietary supplement, blindly purchase it, and never […]

Continue Reading →

Posted on by and in , , | 46 Comments

How to Avoid False Advertising Lawsuits in the Food & Supplementation Industry

While we at PricePlow love to talk about new brands, product releases, and new flavor variations, we strive to remain up-to-date with the business side of things within the supplement industry. It’s sometimes easy to neglect the inner workings of […]

Continue Reading →

Posted on by in | No Comments

Dynamine Achieves GRAS Status With Several New Safety Studies!

Dynamine Caffeine

In early 2018, we wrote the first major article about Dynamine, the patented neuro-activating “stimulant” sold by Compound Solutions. More technically referred to as Methylliberine, the ingredient has since been put into countless pre workout supplements, fat burners, […]

Continue Reading →

Posted on by in , , , | No Comments

Supplement Facts vs Nutrition Facts and Protein Powder. NutraBio Was Right (Again).

Supplement Facts vs. Nutrition Facts

Last week, when I was reviewing the new Strawberry Ice Cream flavor of NutraBio’s 100% Whey Protein Isolate, I stumbled on something “odd” when I was going over the label. I couldn’t find fat!

What gives? Where is the […]

Continue Reading →

Posted on by in | No Comments

Premier Protein LAWSUIT Settlement: Get Up to $40 Back!

Premier Protein Lawsuit

Did you ever buy Premier Protein Shakes between August 8, 2011 and October 12, 2018?

If so, then you’re entitled to some money back — up to $40.00 sent in the mail!

The important links

Cutting to the chase, let’s […]

Continue Reading →

Posted on by in , | 4 Comments

Thaumatin (Katemfe Fruit Extract): Natural Low-Calorie Sweetener

Thaumatin

When purchasing supplements, the leading factor in consumer’s decision should be ingredient effectiveness. If a pre-workout doesn’t have the right ingreedients to help you get a great workout, then why buy it?

However, what really separates good products from […]

Continue Reading →

Posted on by in , , | 1 Comment

Mark Glazier Lobbies Congress for Better Protein Labeling Laws | #016

PricePlow Podcast #016 - Mark Glazier NutraBio Lobbying Congress for Better Protein Labeling Laws

In May of 2018, Mike and Mark Glazier talked about Mark’s recent trip to Washington D.C. (posted here on Mark’s Facebook and embedded below), where the NutraBio founder and CEO was lobbying for better protein labeling laws.

Mark explains some […]

Continue Reading →

Posted on by in , | No Comments

CBD Law 2018 Update: CBD No Longer a Schedule 1 Controlled Substance**

CBD Controlled Substances

By: Jay Manfre, Esq.
Collins Gann McCloskey & Barry, PLLC
https://supplementcounsel.com Disclaimer: This post is for informational purposes only; not to be construed as legal advice. Attorney Advertising.

**Only if it is an FDA-approved CBD drug with no more than […]

Continue Reading →

Posted on by and in , , , | 2 Comments

DMAA FDA Lawsuit Appeal Oral Arguments: Hi-Tech Gets Their Day in Court

Hi-Tech DMAA Lawsuit Appeal

In March of 2018, we were left with Hi-Tech Pharmaceuticals’ appeal to the Eleventh Circuit court over their DMAA lawsuit against the FDA. Before we get into the update, a quick recap:

Hi-Tech appealed the ruling of district court […]

Continue Reading →

Posted on by in | 2 Comments